Login to Your Account

Tesaro Turns to Public Markets for Next 12 Months' Cash

By Catherine Shaffer
Staff Writer

Thursday, February 21, 2013
Tesaro Inc. topped up its cash with a $75 million public offering to support development and clinical trials of its oncology pipeline products. The company expects net proceeds of $69.7 million to support operations for the next 12 months.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription